BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 799252 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-3-2-4-11(16)5-9/h2-7,19H,8H2,1H3,(H,18,21) LQWXMRRGVHUWEN-UHFFFAOYSA-N 107695 US11426393, Compound Table XV.1::US8598210, Table XV, 1::US8722895, 1: {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2- carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00126::USRE47437, Example {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Egl nine homolog 1 Homo sapiens 2800 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107695&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891582 186524565 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799253 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-3-2-4-11(16)5-9/h2-7,19H,8H2,1H3,(H,18,21) LQWXMRRGVHUWEN-UHFFFAOYSA-N 107695 US11426393, Compound Table XV.1::US8598210, Table XV, 1::US8722895, 1: {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2- carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00126::USRE47437, Example {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Prolyl hydroxylase EGLN3 Homo sapiens 21400 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107695&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891582 186524565 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799254 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-3-2-4-11(16)5-9/h2-7,19H,8H2,1H3,(H,18,21) LQWXMRRGVHUWEN-UHFFFAOYSA-N 107695 US11426393, Compound Table XV.1::US8598210, Table XV, 1::US8722895, 1: {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2- carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00126::USRE47437, Example {[5-(3-chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Vascular endothelial growth factor A Homo sapiens 9900 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107695&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891582 186524565 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799255 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(Cl)cc1 InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-2-4-11(16)5-3-9/h2-7,19H,8H2,1H3,(H,18,21) BYGKIXAXITXFDW-UHFFFAOYSA-N 107696 US11426393, Compound Table XV.2::US8598210, Table XV, 2::US8722895, 2: {[5-(4-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00127::USRE47437, Example {[5-(4-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Egl nine homolog 1 Homo sapiens 3700 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107696&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891583 186524566 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799256 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(Cl)cc1 InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-2-4-11(16)5-3-9/h2-7,19H,8H2,1H3,(H,18,21) BYGKIXAXITXFDW-UHFFFAOYSA-N 107696 US11426393, Compound Table XV.2::US8598210, Table XV, 2::US8722895, 2: {[5-(4-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00127::USRE47437, Example {[5-(4-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Vascular endothelial growth factor A Homo sapiens >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107696&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891583 186524566 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799257 COC(=O)CNC(=O)c2ncc(c1ccc(C#N)cc1)cc2O InChI=1S/C16H13N3O4/c1-23-14(21)9-19-16(22)15-13(20)6-12(8-18-15)11-4-2-10(7-17)3-5-11/h2-6,8,20H,9H2,1H3,(H,19,22) JCZYBWBAIMAABM-UHFFFAOYSA-N 301787 US9598370, Example 00128::USRE47437, Example {[5-(4-Cyano-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.3 Egl nine homolog 1 Human 5800 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301787&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891535 381750529 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 hypoxia-inducible factor-proline dioxygenase R4SCQ0_HUMAN R4SCQ0 799258 COC(=O)CNC(=O)c2ncc(c1ccc(C#N)cc1)cc2O InChI=1S/C16H13N3O4/c1-23-14(21)9-19-16(22)15-13(20)6-12(8-18-15)11-4-2-10(7-17)3-5-11/h2-6,8,20H,9H2,1H3,(H,19,22) JCZYBWBAIMAABM-UHFFFAOYSA-N 301787 US9598370, Example 00128::USRE47437, Example {[5-(4-Cyano-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.3 Vascular endothelial growth factor A Human >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301787&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891535 381750529 1 MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 6V7K,9KKU,9JU1,6D3O,5HHD,5HHC,4WPB,4GLU,4GLS,4GLN,3S1K,3QTK,3BDY,2VPF,2FJH,2FJG,1VPP,1VPF,1TZI,1TZH,1QTY,1BJ1,7LL9,7LL8,6BFT,4ZFF,1KAT,1FLT,2QR0,3S1B,6ZFL,5O4E,6ZCD,6ZBR,6Z3F,6Z13,1CZ8,4DEQ,2VGH,1VGH,1KMX,5DN2 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799259 Cc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C15H14N2O4/c1-9-2-4-10(5-3-9)11-6-12(18)14(16-7-11)15(21)17-8-13(19)20/h2-7,18H,8H2,1H3,(H,17,21)(H,19,20) VBNCAZJDNCXKIO-UHFFFAOYSA-N 107698 US11426393, Compound Table XV.4::US8598210, Table XV, 4::US8722895, 4: [(3-Hydroxy-5-(4-methylphenyl)pyridine-2- carbonyl)amino]-acetic acid::US9598370, Example 00129::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)pyridine-2-carbonyl)amino]-acetic acid Egl nine homolog 1 Homo sapiens 650 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107698&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891734 186524568 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799260 Cc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C15H14N2O4/c1-9-2-4-10(5-3-9)11-6-12(18)14(16-7-11)15(21)17-8-13(19)20/h2-7,18H,8H2,1H3,(H,17,21)(H,19,20) VBNCAZJDNCXKIO-UHFFFAOYSA-N 107698 US11426393, Compound Table XV.4::US8598210, Table XV, 4::US8722895, 4: [(3-Hydroxy-5-(4-methylphenyl)pyridine-2- carbonyl)amino]-acetic acid::US9598370, Example 00129::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)pyridine-2-carbonyl)amino]-acetic acid Prolyl hydroxylase EGLN3 Homo sapiens 180 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107698&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891734 186524568 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799261 Cc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C15H14N2O4/c1-9-2-4-10(5-3-9)11-6-12(18)14(16-7-11)15(21)17-8-13(19)20/h2-7,18H,8H2,1H3,(H,17,21)(H,19,20) VBNCAZJDNCXKIO-UHFFFAOYSA-N 107698 US11426393, Compound Table XV.4::US8598210, Table XV, 4::US8722895, 4: [(3-Hydroxy-5-(4-methylphenyl)pyridine-2- carbonyl)amino]-acetic acid::US9598370, Example 00129::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)pyridine-2-carbonyl)amino]-acetic acid Vascular endothelial growth factor A Homo sapiens 42100 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107698&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891734 186524568 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799262 Cc1ccc(cc1)-c1ccc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C16H15NO4/c1-10-2-4-11(5-3-10)12-6-7-13(14(18)8-12)16(21)17-9-15(19)20/h2-8,18H,9H2,1H3,(H,17,21)(H,19,20) POKDHYRFSOQLCV-UHFFFAOYSA-N 107699 US11426393, Compound Table XV.5::US8598210, Table XV, 5::US8722895, 5: [(3-Hydroxy-4'-methyl-biphenyl-4- carbonyl)-amino]-acetic acid::US9598370, Example 00130::USRE47437, Example [(3-Hydroxy-4'-methyl-biphenyl-4-carbonyl)-amino]-acetic acid Egl nine homolog 1 Homo sapiens 20000 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107699&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891042 186524569 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799263 Cc1ccc(cc1)-c1ccc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C16H15NO4/c1-10-2-4-11(5-3-10)12-6-7-13(14(18)8-12)16(21)17-9-15(19)20/h2-8,18H,9H2,1H3,(H,17,21)(H,19,20) POKDHYRFSOQLCV-UHFFFAOYSA-N 107699 US11426393, Compound Table XV.5::US8598210, Table XV, 5::US8722895, 5: [(3-Hydroxy-4'-methyl-biphenyl-4- carbonyl)-amino]-acetic acid::US9598370, Example 00130::USRE47437, Example [(3-Hydroxy-4'-methyl-biphenyl-4-carbonyl)-amino]-acetic acid Vascular endothelial growth factor A Homo sapiens >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107699&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891042 186524569 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799264 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(C)cc1 InChI=1S/C16H16N2O4/c1-10-3-5-11(6-4-10)12-7-13(19)15(17-8-12)16(21)18-9-14(20)22-2/h3-8,19H,9H2,1-2H3,(H,18,21) DSAKFJKYBXTHSR-UHFFFAOYSA-N 107700 US11426393, Compound Table XV.6::US8598210, Table XV, 6::US8722895, 6: [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2- carbonyl)-amino]-acetic acid methyl ester::US9598370, Example 00131::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2-carbonyl)-amino]-acetic acid methyl ester Egl nine homolog 1 Homo sapiens 4100 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107700&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891584 186524570 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799265 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(C)cc1 InChI=1S/C16H16N2O4/c1-10-3-5-11(6-4-10)12-7-13(19)15(17-8-12)16(21)18-9-14(20)22-2/h3-8,19H,9H2,1-2H3,(H,18,21) DSAKFJKYBXTHSR-UHFFFAOYSA-N 107700 US11426393, Compound Table XV.6::US8598210, Table XV, 6::US8722895, 6: [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2- carbonyl)-amino]-acetic acid methyl ester::US9598370, Example 00131::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2-carbonyl)-amino]-acetic acid methyl ester Prolyl hydroxylase EGLN3 Homo sapiens 52300 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107700&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891584 186524570 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799266 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(C)cc1 InChI=1S/C16H16N2O4/c1-10-3-5-11(6-4-10)12-7-13(19)15(17-8-12)16(21)18-9-14(20)22-2/h3-8,19H,9H2,1-2H3,(H,18,21) DSAKFJKYBXTHSR-UHFFFAOYSA-N 107700 US11426393, Compound Table XV.6::US8598210, Table XV, 6::US8722895, 6: [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2- carbonyl)-amino]-acetic acid methyl ester::US9598370, Example 00131::USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2-carbonyl)-amino]-acetic acid methyl ester Vascular endothelial growth factor A Homo sapiens 8200 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107700&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891584 186524570 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799267 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-9(7-17-14)10-4-2-3-5-11(10)16/h2-7,19H,8H2,1H3,(H,18,21) BYSUDLAKLIQTEQ-UHFFFAOYSA-N 107701 US11426393, Compound Table XV.7::US8598210, Table XV, 7::US8722895, 7: {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00132::USRE47437, Example {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Egl nine homolog 1 Homo sapiens 6800 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107701&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891581 186524571 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799268 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-9(7-17-14)10-4-2-3-5-11(10)16/h2-7,19H,8H2,1H3,(H,18,21) BYSUDLAKLIQTEQ-UHFFFAOYSA-N 107701 US11426393, Compound Table XV.7::US8598210, Table XV, 7::US8722895, 7: {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00132::USRE47437, Example {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Prolyl hydroxylase EGLN3 Homo sapiens 37500 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107701&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891581 186524571 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799269 COC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl InChI=1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-9(7-17-14)10-4-2-3-5-11(10)16/h2-7,19H,8H2,1H3,(H,18,21) BYSUDLAKLIQTEQ-UHFFFAOYSA-N 107701 US11426393, Compound Table XV.7::US8598210, Table XV, 7::US8722895, 7: {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine- 2-carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00132::USRE47437, Example {[5-(2-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester Vascular endothelial growth factor A Homo sapiens 7700 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107701&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891581 186524571 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799270 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(cc1)C#N InChI=1S/C15H11N3O4/c16-6-9-1-3-10(4-2-9)11-5-12(19)14(17-7-11)15(22)18-8-13(20)21/h1-5,7,19H,8H2,(H,18,22)(H,20,21) FUWDGRQRRUDDDA-UHFFFAOYSA-N 301799 US11426393, Compound Table XV.8::US9598370, Example 00133::USRE47437, Example {[5-(4-Cyanophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 99000 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301799&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891736 381750541 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799271 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(cc1)C#N InChI=1S/C15H11N3O4/c16-6-9-1-3-10(4-2-9)11-5-12(19)14(17-7-11)15(22)18-8-13(20)21/h1-5,7,19H,8H2,(H,18,22)(H,20,21) FUWDGRQRRUDDDA-UHFFFAOYSA-N 301799 US11426393, Compound Table XV.8::US9598370, Example 00133::USRE47437, Example {[5-(4-Cyanophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Prolyl hydroxylase EGLN3 Homo sapiens 560 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301799&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891736 381750541 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799272 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(cc1)C#N InChI=1S/C15H11N3O4/c16-6-9-1-3-10(4-2-9)11-5-12(19)14(17-7-11)15(22)18-8-13(20)21/h1-5,7,19H,8H2,(H,18,22)(H,20,21) FUWDGRQRRUDDDA-UHFFFAOYSA-N 301799 US11426393, Compound Table XV.8::US9598370, Example 00133::USRE47437, Example {[5-(4-Cyanophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Vascular endothelial growth factor A Homo sapiens 4300 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301799&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891736 381750541 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799273 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(Cl)cc1 InChI=1S/C14H11ClN2O4/c15-10-3-1-8(2-4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) DLUPTLSWWQTJFJ-UHFFFAOYSA-N 107703 US10889546, US2007/0299086 Table 2.4::US11426393, Compound Table XV.9::US8598210, Table XV, 9::US8722895, 9: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00134::USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 240 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107703&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891686 186524573 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799274 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(Cl)cc1 InChI=1S/C14H11ClN2O4/c15-10-3-1-8(2-4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) DLUPTLSWWQTJFJ-UHFFFAOYSA-N 107703 US10889546, US2007/0299086 Table 2.4::US11426393, Compound Table XV.9::US8598210, Table XV, 9::US8722895, 9: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00134::USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Prolyl hydroxylase EGLN3 Homo sapiens 83.0 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107703&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891686 186524573 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799275 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) JGRXMPYUTJLTKT-UHFFFAOYSA-N 107704 US11426393, Compound Table XV.11::US8598210, 119::US8598210, Table XV, 10::US8598210, Table XV, 11::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 410 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107704&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search A1Z 7UMP,5OPC,5OX6 23634441 186524574 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799276 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) JGRXMPYUTJLTKT-UHFFFAOYSA-N 107704 US11426393, Compound Table XV.11::US8598210, 119::US8598210, Table XV, 10::US8598210, Table XV, 11::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Vascular endothelial growth factor A Homo sapiens 7600 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107704&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search A1Z 7UMP,5OPC,5OX6 23634441 186524574 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799277 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) JGRXMPYUTJLTKT-UHFFFAOYSA-N 107704 US11426393, Compound Table XV.11::US8598210, 119::US8598210, Table XV, 10::US8598210, Table XV, 11::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 1100 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107704&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search A1Z 7UMP,5OPC,5OX6 23634441 186524574 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799278 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) JGRXMPYUTJLTKT-UHFFFAOYSA-N 107704 US11426393, Compound Table XV.11::US8598210, 119::US8598210, Table XV, 10::US8598210, Table XV, 11::US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt::US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00136::USRE47437, Example {[5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Prolyl hydroxylase EGLN3 Homo sapiens 390 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107704&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search A1Z 23634441 186524574 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799279 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl InChI=1S/C14H11ClN2O4/c15-10-4-2-1-3-9(10)8-5-11(18)13(16-6-8)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) ULLZYMRNGQLQCT-UHFFFAOYSA-N 107706 US11426393, Compound Table XV.12::US8598210, Table XV, 12::US8722895, 12: {[5-(2-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00137::USRE47437, Example {[5-(2-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 1100 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107706&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891688 186524576 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799280 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccccc1Cl InChI=1S/C14H11ClN2O4/c15-10-4-2-1-3-9(10)8-5-11(18)13(16-6-8)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) ULLZYMRNGQLQCT-UHFFFAOYSA-N 107706 US11426393, Compound Table XV.12::US8598210, Table XV, 12::US8722895, 12: {[5-(2-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00137::USRE47437, Example {[5-(2-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Prolyl hydroxylase EGLN3 Homo sapiens 390 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107706&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891688 186524576 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799281 CC(C)c1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C17H18N2O4/c1-10(2)11-3-5-12(6-4-11)13-7-14(20)16(18-8-13)17(23)19-9-15(21)22/h3-8,10,20H,9H2,1-2H3,(H,19,23)(H,21,22) XZPLTNPEACHLGV-UHFFFAOYSA-N 107707 US11426393, Compound Table XV.13::US8598210, Table XV, 13::US8722895, 13: {[5-(4-Isopropylphenyl)-3-hydroxypyridine- 2-carbonyl]amino}-acetic acid::US9598370, Example 00138::USRE47437, Example {[5-(4-Isopropylphenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 440 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107707&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891735 186524577 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799282 CC(C)c1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C17H18N2O4/c1-10(2)11-3-5-12(6-4-11)13-7-14(20)16(18-8-13)17(23)19-9-15(21)22/h3-8,10,20H,9H2,1-2H3,(H,19,23)(H,21,22) XZPLTNPEACHLGV-UHFFFAOYSA-N 107707 US11426393, Compound Table XV.13::US8598210, Table XV, 13::US8722895, 13: {[5-(4-Isopropylphenyl)-3-hydroxypyridine- 2-carbonyl]amino}-acetic acid::US9598370, Example 00138::USRE47437, Example {[5-(4-Isopropylphenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Vascular endothelial growth factor A Homo sapiens 15000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107707&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891735 186524577 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799283 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(F)cc1 InChI=1S/C14H11FN2O4/c15-10-3-1-8(2-4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) XTAXWQIDORMKHA-UHFFFAOYSA-N 107708 US11426393, Compound Table XV.14::US8598210, Table XV, 14::US8722895, 14: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00139::USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 300 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107708&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891687 186524578 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799284 OC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(F)cc1 InChI=1S/C14H11FN2O4/c15-10-3-1-8(2-4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) XTAXWQIDORMKHA-UHFFFAOYSA-N 107708 US11426393, Compound Table XV.14::US8598210, Table XV, 14::US8722895, 14: {[5-(4-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid::US9598370, Example 00139::USRE47437, Example {[5-(4-Chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Vascular endothelial growth factor A Homo sapiens >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107708&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891687 186524578 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799285 CC(C)Oc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C17H18N2O5/c1-10(2)24-13-5-3-11(4-6-13)12-7-14(20)16(18-8-12)17(23)19-9-15(21)22/h3-8,10,20H,9H2,1-2H3,(H,19,23)(H,21,22) XAQQOGZYOJAKKO-UHFFFAOYSA-N 107709 US11426393, Compound Table XV.15::US8598210, Table XV, 15::US8722895, 15: {[5-(4-Isopropoxyphenyl)-3- hydroxypyridine-2-carbonyl]amino}-acetic acid::US9598370, Example 00140::USRE47437, Example {[5-(4-Isopropoxyphenyl)-3-hydroxypyridine-2-carbonyl]amino}-aceticacid Egl nine homolog 1 Homo sapiens 1600 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107709&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24890990 186524579 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799286 CC(C)Oc1ccc(cc1)-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C17H18N2O5/c1-10(2)24-13-5-3-11(4-6-13)12-7-14(20)16(18-8-12)17(23)19-9-15(21)22/h3-8,10,20H,9H2,1-2H3,(H,19,23)(H,21,22) XAQQOGZYOJAKKO-UHFFFAOYSA-N 107709 US11426393, Compound Table XV.15::US8598210, Table XV, 15::US8722895, 15: {[5-(4-Isopropoxyphenyl)-3- hydroxypyridine-2-carbonyl]amino}-acetic acid::US9598370, Example 00140::USRE47437, Example {[5-(4-Isopropoxyphenyl)-3-hydroxypyridine-2-carbonyl]amino}-aceticacid Vascular endothelial growth factor A Homo sapiens >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107709&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24890990 186524579 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799287 Cc1ccc(Cl)cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C15H13ClN2O4/c1-8-2-3-10(16)5-11(8)9-4-12(19)14(17-6-9)15(22)18-7-13(20)21/h2-6,19H,7H2,1H3,(H,18,22)(H,20,21) XFZFCHHQSHMUBB-UHFFFAOYSA-N 107710 US11426393, Compound Table XV.16::US8598210, Table XV, 16::US8722895, 16: {[5-(2-Methyl-5-chlorophenyl)-3- hydroxypyridine-2-carbonyl]amino}-acetic acid::US9598370, Example 00141::USRE47437, Example {[5-(2-Methyl-5-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-aceticacid Egl nine homolog 1 Homo sapiens 2500 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107710&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891737 186524580 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799288 Cc1ccc(Cl)cc1-c1cnc(C(=O)NCC(O)=O)c(O)c1 InChI=1S/C15H13ClN2O4/c1-8-2-3-10(16)5-11(8)9-4-12(19)14(17-6-9)15(22)18-7-13(20)21/h2-6,19H,7H2,1H3,(H,18,22)(H,20,21) XFZFCHHQSHMUBB-UHFFFAOYSA-N 107710 US11426393, Compound Table XV.16::US8598210, Table XV, 16::US8722895, 16: {[5-(2-Methyl-5-chlorophenyl)-3- hydroxypyridine-2-carbonyl]amino}-acetic acid::US9598370, Example 00141::USRE47437, Example {[5-(2-Methyl-5-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-aceticacid Vascular endothelial growth factor A Homo sapiens 3300 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107710&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891737 186524580 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799289 CNC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C15H14ClN3O3/c1-17-13(21)8-19-15(22)14-12(20)6-10(7-18-14)9-3-2-4-11(16)5-9/h2-7,20H,8H2,1H3,(H,17,21)(H,19,22) FLEKXPKWSFKURA-UHFFFAOYSA-N 107711 US11426393, Compound Table XV.17::US8598210, Table XV, 17::US8722895, 17: 5-(3-Chlorophenyl)-N-(2-methylamino-2- oxoethyl)-3-hydroxypyridin-2-yl amide::US9598370, Example 00142::USRE47437, Example 5-(3-Chlorophenyl)-N-(2-methylamino-2-oxoethyl)-3-hydroxypyridin-2-yl amide Egl nine homolog 1 Homo sapiens 1200 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107711&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891044 186524581 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799290 CNC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C15H14ClN3O3/c1-17-13(21)8-19-15(22)14-12(20)6-10(7-18-14)9-3-2-4-11(16)5-9/h2-7,20H,8H2,1H3,(H,17,21)(H,19,22) FLEKXPKWSFKURA-UHFFFAOYSA-N 107711 US11426393, Compound Table XV.17::US8598210, Table XV, 17::US8722895, 17: 5-(3-Chlorophenyl)-N-(2-methylamino-2- oxoethyl)-3-hydroxypyridin-2-yl amide::US9598370, Example 00142::USRE47437, Example 5-(3-Chlorophenyl)-N-(2-methylamino-2-oxoethyl)-3-hydroxypyridin-2-yl amide Prolyl hydroxylase EGLN3 Homo sapiens 1300 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5442&target=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107711&enzyme=Prolyl+hydroxylase+EGLN3&column=ki&startPg=0&Increment=50&submit=Search 24891044 186524581 1 MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED Prolyl hydroxylase EGLN3 EGLN3_HUMAN Q9H6Z9 Q2TA79 Q3B8N4 Q6P1R2 799291 CNC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 InChI=1S/C15H14ClN3O3/c1-17-13(21)8-19-15(22)14-12(20)6-10(7-18-14)9-3-2-4-11(16)5-9/h2-7,20H,8H2,1H3,(H,17,21)(H,19,22) FLEKXPKWSFKURA-UHFFFAOYSA-N 107711 US11426393, Compound Table XV.17::US8598210, Table XV, 17::US8722895, 17: 5-(3-Chlorophenyl)-N-(2-methylamino-2- oxoethyl)-3-hydroxypyridin-2-yl amide::US9598370, Example 00142::USRE47437, Example 5-(3-Chlorophenyl)-N-(2-methylamino-2-oxoethyl)-3-hydroxypyridin-2-yl amide Vascular endothelial growth factor A Homo sapiens 1400 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107711&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891044 186524581 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799292 COC(=O)CNC(=O)c2ncc(c1cccc(C#N)c1)cc2O InChI=1S/C16H13N3O4/c1-23-14(21)9-19-16(22)15-13(20)6-12(8-18-15)11-4-2-3-10(5-11)7-17/h2-6,8,20H,9H2,1H3,(H,19,22) AHTBIZZHFITLNF-UHFFFAOYSA-N 301819 US9598370, Example 00143::USRE47437, Example {[5-(3-Cyano-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.18 Egl nine homolog 1 Human 5100 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301819&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891633 381750561 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 hypoxia-inducible factor-proline dioxygenase R4SCQ0_HUMAN R4SCQ0 799293 COC(=O)CNC(=O)c2ncc(c1cccc(C#N)c1)cc2O InChI=1S/C16H13N3O4/c1-23-14(21)9-19-16(22)15-13(20)6-12(8-18-15)11-4-2-3-10(5-11)7-17/h2-6,8,20H,9H2,1H3,(H,19,22) AHTBIZZHFITLNF-UHFFFAOYSA-N 301819 US9598370, Example 00143::USRE47437, Example {[5-(3-Cyano-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US11426393, Compound Table XV.18 Vascular endothelial growth factor A Human >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301819&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891633 381750561 1 MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 6V7K,9KKU,9JU1,6D3O,5HHD,5HHC,4WPB,4GLU,4GLS,4GLN,3S1K,3QTK,3BDY,2VPF,2FJH,2FJG,1VPP,1VPF,1TZI,1TZH,1QTY,1BJ1,7LL9,7LL8,6BFT,4ZFF,1KAT,1FLT,2QR0,3S1B,6ZFL,5O4E,6ZCD,6ZBR,6Z3F,6Z13,1CZ8,4DEQ,2VGH,1VGH,1KMX,5DN2 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799294 COC(=O)CNC(=O)c3ncc(c2cccc(c1nn[nH]n1)c2)cc3O InChI=1S/C16H14N6O4/c1-26-13(24)8-18-16(25)14-12(23)6-11(7-17-14)9-3-2-4-10(5-9)15-19-21-22-20-15/h2-7,23H,8H2,1H3,(H,18,25)(H,19,20,21,22) YSPBNSRKQJFWJL-UHFFFAOYSA-N 301820 US9598370, Example 00144::USRE47437, Example ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)-phenyl]-pyridine-2-carbonyl}-amino)-aceticacid methyl ester::US11426393, Compound Table XV.19 Egl nine homolog 1 Human 2600 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301820&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891638 381750562 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 hypoxia-inducible factor-proline dioxygenase R4SCQ0_HUMAN R4SCQ0 799295 COC(=O)CNC(=O)c3ncc(c2cccc(c1nn[nH]n1)c2)cc3O InChI=1S/C16H14N6O4/c1-26-13(24)8-18-16(25)14-12(23)6-11(7-17-14)9-3-2-4-10(5-9)15-19-21-22-20-15/h2-7,23H,8H2,1H3,(H,18,25)(H,19,20,21,22) YSPBNSRKQJFWJL-UHFFFAOYSA-N 301820 US9598370, Example 00144::USRE47437, Example ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)-phenyl]-pyridine-2-carbonyl}-amino)-aceticacid methyl ester::US11426393, Compound Table XV.19 Vascular endothelial growth factor A Human >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301820&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891638 381750562 1 MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 6V7K,9KKU,9JU1,6D3O,5HHD,5HHC,4WPB,4GLU,4GLS,4GLN,3S1K,3QTK,3BDY,2VPF,2FJH,2FJG,1VPP,1VPF,1TZI,1TZH,1QTY,1BJ1,7LL9,7LL8,6BFT,4ZFF,1KAT,1FLT,2QR0,3S1B,6ZFL,5O4E,6ZCD,6ZBR,6Z3F,6Z13,1CZ8,4DEQ,2VGH,1VGH,1KMX,5DN2 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799296 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C#N InChI=1S/C15H11N3O4/c16-6-9-2-1-3-10(4-9)11-5-12(19)14(17-7-11)15(22)18-8-13(20)21/h1-5,7,19H,8H2,(H,18,22)(H,20,21) MPVNTWTVHVEUKG-UHFFFAOYSA-N 400041 US11426393, Compound Table XV.20::USRE47437, Example {[5-(3-Cyanophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Egl nine homolog 1 Homo sapiens 190 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=400041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=400041&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891733 405260070 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799297 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C#N InChI=1S/C15H11N3O4/c16-6-9-2-1-3-10(4-9)11-5-12(19)14(17-7-11)15(22)18-8-13(20)21/h1-5,7,19H,8H2,(H,18,22)(H,20,21) MPVNTWTVHVEUKG-UHFFFAOYSA-N 400041 US11426393, Compound Table XV.20::USRE47437, Example {[5-(3-Cyanophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid Vascular endothelial growth factor A Homo sapiens >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=400041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=400041&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891733 405260070 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799298 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(N)=O InChI=1S/C16H15N3O5/c1-24-13(21)8-19-16(23)14-12(20)6-11(7-18-14)9-3-2-4-10(5-9)15(17)22/h2-7,20H,8H2,1H3,(H2,17,22)(H,19,23) MWJDKCNAPFXDPO-UHFFFAOYSA-N 107715 US11426393, Compound Table XV.21::US8598210, Table XV, 21::US8722895, 21: {[5-(3-Carbamoyl-phenyl)-3-hydroxy- pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00146::USRE47437, Example {[5-(3-Carbamoyl-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acidmethyl ester Egl nine homolog 1 Homo sapiens 11200 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107715&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891634 186524585 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799299 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(N)=O InChI=1S/C16H15N3O5/c1-24-13(21)8-19-16(23)14-12(20)6-11(7-18-14)9-3-2-4-10(5-9)15(17)22/h2-7,20H,8H2,1H3,(H2,17,22)(H,19,23) MWJDKCNAPFXDPO-UHFFFAOYSA-N 107715 US11426393, Compound Table XV.21::US8598210, Table XV, 21::US8722895, 21: {[5-(3-Carbamoyl-phenyl)-3-hydroxy- pyridine-2-carbonyl]-amino}-acetic acid methyl ester::US9598370, Example 00146::USRE47437, Example {[5-(3-Carbamoyl-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acidmethyl ester Vascular endothelial growth factor A Homo sapiens 50100 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107715&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891634 186524585 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799300 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(=O)N1CCCC1 InChI=1S/C20H21N3O5/c1-28-17(25)12-22-19(26)18-16(24)10-15(11-21-18)13-5-4-6-14(9-13)20(27)23-7-2-3-8-23/h4-6,9-11,24H,2-3,7-8,12H2,1H3,(H,22,26) HBZHWXZOIFSLHR-UHFFFAOYSA-N 107716 US11426393, Compound Table XV.22::US8598210, Table XV, 22::US8722895, 22: ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)- phenyl]-pyridine-2-carbonyl}-amino)-acetic acid methyl ester::US9598370, Example 00147::USRE47437, Example ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)-phenyl]-pyridine-2-carbonyl}-amino)-aceticacid methyl ester Egl nine homolog 1 Homo sapiens 2500 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107716&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891635 186524586 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799301 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(=O)N1CCCC1 InChI=1S/C20H21N3O5/c1-28-17(25)12-22-19(26)18-16(24)10-15(11-21-18)13-5-4-6-14(9-13)20(27)23-7-2-3-8-23/h4-6,9-11,24H,2-3,7-8,12H2,1H3,(H,22,26) HBZHWXZOIFSLHR-UHFFFAOYSA-N 107716 US11426393, Compound Table XV.22::US8598210, Table XV, 22::US8722895, 22: ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)- phenyl]-pyridine-2-carbonyl}-amino)-acetic acid methyl ester::US9598370, Example 00147::USRE47437, Example ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)-phenyl]-pyridine-2-carbonyl}-amino)-aceticacid methyl ester Vascular endothelial growth factor A Homo sapiens >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107716&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24891635 186524586 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799302 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(=O)N1CCCC1 InChI=1S/C19H19N3O5/c23-15-9-14(10-20-17(15)18(26)21-11-16(24)25)12-4-3-5-13(8-12)19(27)22-6-1-2-7-22/h3-5,8-10,23H,1-2,6-7,11H2,(H,21,26)(H,24,25) FPDULEQZUNAQKE-UHFFFAOYSA-N 107717 US11426393, Compound Table XV.23::US8598210, Table XV, 23::US8722895, 23: ({3-Hydroxy-5-[3-(pyrrolidine-1- carbonyl)phenyl]-pyridine-2- carbonyl}amino)-acetic acid::US9598370, Example 00148::USRE47437, Example ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)phenyl]-pyridine-2-carbonyl}amino)-acetic acid Egl nine homolog 1 Homo sapiens 300 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107717&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24890988 186524587 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 799303 OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(c1)C(=O)N1CCCC1 InChI=1S/C19H19N3O5/c23-15-9-14(10-20-17(15)18(26)21-11-16(24)25)12-4-3-5-13(8-12)19(27)22-6-1-2-7-22/h3-5,8-10,23H,1-2,6-7,11H2,(H,21,26)(H,24,25) FPDULEQZUNAQKE-UHFFFAOYSA-N 107717 US11426393, Compound Table XV.23::US8598210, Table XV, 23::US8722895, 23: ({3-Hydroxy-5-[3-(pyrrolidine-1- carbonyl)phenyl]-pyridine-2- carbonyl}amino)-acetic acid::US9598370, Example 00148::USRE47437, Example ({3-Hydroxy-5-[3-(pyrrolidine-1-carbonyl)phenyl]-pyridine-2-carbonyl}amino)-acetic acid Vascular endothelial growth factor A Homo sapiens >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107717&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24890988 186524587 1 MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 1CZ8,1FLT,1KAT,1QTY,1TZH,1TZI,1VPF,1VPP,2FJG,2FJH,2QR0,2VPF,3BDY,3QTK,3S1B,3S1K,4DEQ,4GLN,4GLS,4GLU,4WPB,4ZFF,5FV1,5FV2,5HHC,5HHD,5O4E,6BFT,6D3O,6V7K,6Z13,6Z3F,6ZBR,6ZCD,6ZFL,7KEZ,7KF0,7KF1 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799304 O=C(O)CNC(=O)c3ncc(c2cccc(c1nn[nH]n1)c2)cc3O InChI=1S/C15H12N6O4/c22-11-5-10(6-16-13(11)15(25)17-7-12(23)24)8-2-1-3-9(4-8)14-18-20-21-19-14/h1-6,22H,7H2,(H,17,25)(H,23,24)(H,18,19,20,21) JCWZYUTUSRZUAB-UHFFFAOYSA-N 301825 US9598370, Example 00149::USRE47437, Example ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)phenyl]-pyridine-2-carbonyl}-amino)-acetic acid::US11426393, Compound Table XV.24 Egl nine homolog 1 Human 400 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301825&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24890989 381750567 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 6YW0,6YVZ,6YVX,6YVW,6YVT,5OX6,5OX5,5A3U,4BQY,4BQX,4BQW,2Y34,2Y33,8Y0V,7UJV,3HQU,2G1M,5LA9,5L9V,8Z33,8Z32,2HBU,2HBT,2G19,3OUJ,3OUH,5V18,8Q6E,8Q6D,8Q5S,7Q5X,7Q5V,6YW3,6YW2,6YW1,6ST3,6QGV,6ZBO,6ZBN,8J1K,8Z35,8Z31,6NMQ,3OUI Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0 hypoxia-inducible factor-proline dioxygenase R4SCQ0_HUMAN R4SCQ0 799305 O=C(O)CNC(=O)c3ncc(c2cccc(c1nn[nH]n1)c2)cc3O InChI=1S/C15H12N6O4/c22-11-5-10(6-16-13(11)15(25)17-7-12(23)24)8-2-1-3-9(4-8)14-18-20-21-19-14/h1-6,22H,7H2,(H,17,25)(H,23,24)(H,18,19,20,21) JCWZYUTUSRZUAB-UHFFFAOYSA-N 301825 US9598370, Example 00149::USRE47437, Example ({3-Hydroxy-5-[3-(2H-tetrazol-5-yl)phenyl]-pyridine-2-carbonyl}-amino)-acetic acid::US11426393, Compound Table XV.24 Vascular endothelial growth factor A Human >100000 US Patent 10.7270/Q2D50Q9S aid1799239 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5598&target=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301825&enzyme=Vascular+endothelial+growth+factor+A&column=ki&startPg=0&Increment=50&submit=Search 24890989 381750567 1 MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR 6V7K,9KKU,9JU1,6D3O,5HHD,5HHC,4WPB,4GLU,4GLS,4GLN,3S1K,3QTK,3BDY,2VPF,2FJH,2FJG,1VPP,1VPF,1TZI,1TZH,1QTY,1BJ1,7LL9,7LL8,6BFT,4ZFF,1KAT,1FLT,2QR0,3S1B,6ZFL,5O4E,6ZCD,6ZBR,6Z3F,6Z13,1CZ8,4DEQ,2VGH,1VGH,1KMX,5DN2 Vascular endothelial growth factor A, long form VEGFA_HUMAN P15692 B5BU86 H0Y2S8 H0Y407 H0Y414 H0Y462 H0Y8N2 H3BLW7 O60720 O75875 Q074Z4 Q16889 Q5UB46 Q6P0P5 Q96KJ0 Q96L82 Q96NW5 Q9H1W8 Q9H1W9 Q9UH58 Q9UL23 799306 COC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(NC(=O)C2CC2)c1 InChI=1S/C19H19N3O5/c1-27-16(24)10-21-19(26)17-15(23)8-13(9-20-17)12-3-2-4-14(7-12)22-18(25)11-5-6-11/h2-4,7-9,11,23H,5-6,10H2,1H3,(H,21,26)(H,22,25) NJTATWKWAORKQP-UHFFFAOYSA-N 107719 US11426393, Compound Table XV.25::US8598210, Table XV, 25::US8722895, 25: ({5-[3-(cyclopropanecarbonyl-amino)- phenyl]-3-hydroxy-pyridine-2-carbonyl}- amino)-acetic acid methyl ester::US9598370, Example 00150::USRE47437, Example ({5-[3-(Cyclopropanecarbonyl-amino)-phenyl]-3-hydroxy-pyridine-2-carbonyl}-amino)-acetic acid methyl ester Egl nine homolog 1 Homo sapiens 9200 US Patent 10.7270/Q2D50Q9S aid1799238 USRE47437 Kawamoto, RM; Wu, S; Evdokimov, AG; Greis, KD; Boyer, AS; Warshakoon, NC 6/18/2019 5/11/2020 Akebia Therapeutics, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=107719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5440&target=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=107719&enzyme=Egl+nine+homolog+1&column=ki&startPg=0&Increment=50&submit=Search 24891682 186524589 1 MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF 2G19,2G1M,2HBT,2HBU,2Y33,2Y34,3HQU,3OUH,3OUI,3OUJ,4BQW,4BQX,4BQY,5A3U,5L9V,5LA9,5OX5,5OX6,5V18,6NMQ,6QGV,6ST3,6YVT,6YVW,6YVX,6YVZ,6YW0,6YW1,6YW2,6YW3,6ZBN,6ZBO,7Q5V,7Q5X,7UJV Egl nine homolog 1 EGLN1_HUMAN Q9GZT9 Q8N3M8 Q9BZS8 Q9BZT0